- Home
- DCTH vs AEF Comparison
DCTH vs AEF Comparison
Compare DCTH & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- AEF
- Stock Information
- Founded
- DCTH 1988
- AEF 1989
- Country
- DCTH United States
- AEF United States
- Employees
- DCTH N/A
- AEF N/A
- Industry
- DCTH Medical/Dental Instruments
- AEF Finance/Investors Services
- Sector
- DCTH Health Care
- AEF Finance
- Exchange
- DCTH Nasdaq
- AEF Nasdaq
- Market Cap
- DCTH 352.0M
- AEF 268.0M
- IPO Year
- DCTH N/A
- AEF N/A
- Fundamental
- Price
- DCTH $11.87
- AEF $5.43
- Analyst Decision
- DCTH Strong Buy
- AEF
- Analyst Count
- DCTH 4
- AEF 0
- Target Price
- DCTH $21.50
- AEF N/A
- AVG Volume (30 Days)
- DCTH 346.0K
- AEF 92.5K
- Earning Date
- DCTH 11-08-2024
- AEF 01-01-0001
- Dividend Yield
- DCTH N/A
- AEF 7.13%
- EPS Growth
- DCTH N/A
- AEF N/A
- EPS
- DCTH N/A
- AEF 0.57
- Revenue
- DCTH $22,644,000.00
- AEF N/A
- Revenue This Year
- DCTH $1,605.13
- AEF N/A
- Revenue Next Year
- DCTH $111.67
- AEF N/A
- P/E Ratio
- DCTH N/A
- AEF $8.86
- Revenue Growth
- DCTH 945.91
- AEF N/A
- 52 Week Low
- DCTH $3.70
- AEF $4.40
- 52 Week High
- DCTH $13.30
- AEF $5.53
- Technical
- Relative Strength Index (RSI)
- DCTH 51.68
- AEF 55.98
- Support Level
- DCTH $10.75
- AEF $5.25
- Resistance Level
- DCTH $11.59
- AEF $5.45
- Average True Range (ATR)
- DCTH 0.70
- AEF 0.07
- MACD
- DCTH -0.11
- AEF 0.01
- Stochastic Oscillator
- DCTH 24.56
- AEF 67.24
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. It invests in the public equity and fixed income markets of Chile. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, Private Equity, telecommunication services, healthcare, real estate and industrials.